Advertisement
Screener

DYADIC INTERNATIONAL INC (DYAI) Foreign Currency Transaction Gain (Loss), Realized

2.0 / 5 stars · 28/69 Roast Me

DYADIC INTERNATIONAL INC Foreign Currency Transaction Gain (Loss), Realized

DYADIC INTERNATIONAL INC (DYAI) reported Foreign Currency Transaction Gain (Loss), Realized of $8.69 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Cash Flow › Operating Activities

us-gaap:ForeignCurrencyTransactionGainLossRealized · last filed 2026-08-12

  • DYADIC INTERNATIONAL INC foreign currency transaction gain (loss), realized for the quarter ending 2026-06-30 was $8.69K, a 46.00% decline year-over-year.
  • DYADIC INTERNATIONAL INC foreign currency transaction gain (loss), realized for the quarter ending 2026-03-31 was -$9.59K, a 235.62% decline year-over-year.
  • DYADIC INTERNATIONAL INC foreign currency transaction gain (loss), realized for the quarter ending 2025-12-31 was $10.97K, a 28.86% increase year-over-year.
  • DYADIC INTERNATIONAL INC foreign currency transaction gain (loss), realized for the quarter ending 2025-09-30 was $12.76K, a 112.76% increase year-over-year.
  • DYADIC INTERNATIONAL INC foreign currency transaction gain (loss), realized for fiscal 2025 was $46.90K, a 107.88% increase from fiscal 2024.
  • DYADIC INTERNATIONAL INC foreign currency transaction gain (loss), realized for fiscal 2024 was $22.56K.
  • DYADIC INTERNATIONAL INC foreign currency transaction gain (loss), realized for fiscal 2023 was -$38.42K.
  • DYADIC INTERNATIONAL INC foreign currency transaction gain (loss), realized for fiscal 2022 was -$49.92K.
Period endForeign Currency Transaction Gain (Loss), Realized 3 monthForeign Currency Transaction Gain (Loss), Realized 3 month as first filedForeign Currency Transaction Gain (Loss), Realized 6 monthForeign Currency Transaction Gain (Loss), Realized 9 monthForeign Currency Transaction Gain (Loss), Realized 9 month as first filedForeign Currency Transaction Gain (Loss), Realized 12 monthForeign Currency Transaction Gain (Loss), Realized 12 month as first filed
2026-06-30$8.69K
10-Q · filed 2026-08-12
-$898.00
10-Q · filed 2026-08-12
$10.08K
derived: sum of 3 quarters · filed 2026-08-12
$22.83K
derived: sum of 4 quarters · filed 2026-08-12
2026-03-31-$9.59K
10-Q · filed 2026-05-13
$1.38K
derived: sum of 2 quarters · filed 2026-05-13
$14.14K
derived: sum of 3 quarters · filed 2026-05-13
$30.24K
derived: sum of 4 quarters · filed 2026-08-12
2025-12-31$10.97K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
$23.73K
derived: sum of 2 quarters · filed 2026-03-25
$39.83K
derived: sum of 3 quarters · filed 2026-08-12
$46.90K
10-K · filed 2026-03-25
2025-09-30$12.76K
10-Q · filed 2025-11-12
$28.85K
derived: sum of 2 quarters · filed 2026-08-12
$35.92K
10-Q · filed 2025-11-12
$44.44K
derived: sum of 4 quarters · filed 2026-08-12
2025-06-30$16.10K
10-Q · filed 2026-08-12
$23.17K
10-Q · filed 2026-08-12
$31.69K
derived: sum of 3 quarters · filed 2026-08-12
$37.68K
derived: sum of 4 quarters · filed 2026-08-12
2025-03-31$7.07K
10-Q · filed 2026-05-13
-$7.07K
10-Q · filed 2025-05-14
$15.59K
derived: sum of 2 quarters · filed 2026-05-13
$21.58K
derived: sum of 3 quarters · filed 2026-05-13
$18.44K
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31$8.52K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25
$14.51K
derived: sum of 2 quarters · filed 2026-03-25
$11.37K
derived: sum of 3 quarters · filed 2026-03-25
$22.56K
10-K · filed 2026-03-25
-$22.56K
10-K · filed 2025-03-26
2024-09-30$6.00K
10-Q · filed 2025-11-12
-$6.00K
10-Q · filed 2024-11-12
$2.85K
derived: sum of 2 quarters · filed 2025-11-12
$14.04K
10-Q · filed 2025-11-12
-$14.04K
10-Q · filed 2024-11-12
-$2.33K
derived: sum of 4 quarters · filed 2025-11-12
2024-06-30-$3.15K
10-Q · filed 2024-08-13
-$8.05K
10-Q · filed 2024-08-13
-$8.32K
derived: sum of 3 quarters · filed 2025-05-14
-$20.92K
derived: sum of 4 quarters · filed 2025-05-14
2024-03-31-$4.90K
10-Q · filed 2025-05-14
-$5.18K
derived: sum of 2 quarters · filed 2025-05-14
-$17.78K
derived: sum of 3 quarters · filed 2025-05-14
-$32.30K
derived: sum of 4 quarters · filed 2025-05-14
2023-12-31-$274.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26
-$12.87K
derived: sum of 2 quarters · filed 2025-03-26
-$27.39K
derived: sum of 3 quarters · filed 2025-03-26
-$38.42K
10-K · filed 2025-03-26
2023-09-30-$12.60K
10-Q · filed 2024-11-12
-$27.12K
derived: sum of 2 quarters · filed 2024-11-12
-$38.14K
10-Q · filed 2024-11-12
-$64.48K
derived: sum of 4 quarters · filed 2024-11-12
2023-06-30-$14.52K
10-Q · filed 2024-08-13
-$25.54K
10-Q · filed 2024-08-13
-$51.88K
derived: sum of 3 quarters · filed 2024-08-13
-$65.09K
derived: sum of 4 quarters · filed 2024-08-13
2023-03-31-$11.02K
10-Q · filed 2024-05-14
-$37.36K
derived: sum of 2 quarters · filed 2024-05-14
-$50.57K
derived: sum of 3 quarters · filed 2024-05-14
-$71.19K
derived: sum of 4 quarters · filed 2024-05-14
2022-12-31-$26.34K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28
-$39.55K
derived: sum of 2 quarters · filed 2024-03-28
-$60.17K
derived: sum of 3 quarters · filed 2024-03-28
-$49.92K
10-K · filed 2024-03-28
2022-09-30-$13.21K
10-Q · filed 2023-11-08
-$33.83K
derived: sum of 2 quarters · filed 2023-11-08
-$23.58K
10-Q · filed 2023-11-08
-$44.39K
derived: sum of 4 quarters · filed 2023-11-08
2022-06-30-$20.62K
10-Q · filed 2023-08-09
-$10.37K
10-Q · filed 2023-08-09
-$31.19K
derived: sum of 3 quarters · filed 2023-08-09
-$61.19K
derived: sum of 4 quarters · filed 2023-08-09
2022-03-31$10.25K
10-Q · filed 2023-05-10
$10.25M
10-Q · filed 2022-05-12
-$10.56K
derived: sum of 2 quarters · filed 2023-05-10
-$40.57K
derived: sum of 3 quarters · filed 2023-05-10
-$58.37K
derived: sum of 4 quarters · filed 2023-05-10
2021-12-31-$20.81K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29
-$50.81K
derived: sum of 2 quarters · filed 2023-03-29
-$68.62K
derived: sum of 3 quarters · filed 2023-03-29
-$96.89K
10-K · filed 2023-03-29
2021-09-30-$30.00K
10-Q · filed 2022-11-10
-$47.81K
derived: sum of 2 quarters · filed 2022-11-10
-$76.08K
10-Q · filed 2022-11-10
-$28.36M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30-$17.81K
10-Q · filed 2022-08-10
-$46.08K
10-Q · filed 2022-08-10
-$28.33M
derived: sum of 3 quarters · filed 2022-08-10
-$28.31M
derived: sum of 4 quarters · filed 2022-08-10
2021-03-31-$28.27M
10-Q · filed 2022-05-12
-$28.27K
10-Q · filed 2021-05-13
-$28.31M
derived: sum of 2 quarters · filed 2022-05-12
-$28.29M
derived: sum of 3 quarters · filed 2022-05-12
-$28.32M
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31-$36.03K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29
-$19.79K
derived: sum of 2 quarters · filed 2022-03-29
-$51.48K
derived: sum of 3 quarters · filed 2022-03-29
-$62.34K
10-K · filed 2022-03-29
2020-09-30$16.24K
10-Q · filed 2021-11-10
-$15.45K
derived: sum of 2 quarters · filed 2021-11-10
-$26.32K
10-Q · filed 2021-11-10
-$29.35K
derived: sum of 4 quarters · filed 2021-11-10
2020-06-30-$31.69K
10-Q · filed 2021-08-12
-$42.56K
10-Q · filed 2021-08-12
-$45.59K
derived: sum of 3 quarters · filed 2021-08-12
-$59.32K
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31-$10.87K
10-Q · filed 2021-05-13
-$13.90K
derived: sum of 2 quarters · filed 2021-05-13
-$27.63K
derived: sum of 3 quarters · filed 2021-05-13
-$32.56K
derived: sum of 4 quarters · filed 2021-05-13
2019-12-31-$3.03K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30
-$16.76K
derived: sum of 2 quarters · filed 2021-03-30
-$21.69K
derived: sum of 3 quarters · filed 2021-03-30
-$27.73K
10-K · filed 2021-03-30
2019-09-30-$13.73K
10-Q · filed 2020-11-12
-$18.66K
derived: sum of 2 quarters · filed 2020-11-12
-$24.69K
10-Q · filed 2020-11-12
2019-06-30-$4.93K
10-Q · filed 2020-08-13
-$10.97K
10-Q · filed 2020-08-13
2019-03-31-$6.03K
10-Q · filed 2020-05-14
2018-09-30-$12.28K
10-Q · filed 2019-11-13
$2.92K
derived: sum of 2 quarters · filed 2019-11-13
-$1.92K
10-Q · filed 2019-11-13
2018-06-30$15.20K
10-Q · filed 2019-08-13
$10.36K
10-Q · filed 2019-08-13
2018-03-31-$4.84K
10-Q · filed 2019-05-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
BioCardia, Inc. (BCDA)United States$0.016B
Passage BIO, Inc. (PASG)United States$0.015B-0.43
Pluri Inc. (PLUR)$0.014B
INTENSITY THERAPEUTICS, INC. (INTS)United States$0.013B-1.08
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)United States$0.013B-1.05
Jasper Therapeutics, Inc. (JSPR)United States$0.020B-0.37
IN8BIO, INC. (INAB)United States$0.012B-0.76
Estrella Immunopharma, Inc. (ESLA)United States$0.020B
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23